Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on TEVA. Teva Pharmaceutical Industries Limited (TEVA)'s share was trading at $21.31 as of Dec 19 th . TEVA's trailing and forward P/E were 872 and 7.61 respectively according to Yahoo Finance. 5 Highest Paying Countries for Pharmacists A close-up shot of various types of medicines on a table, illustrating the specialty and generic products offered by the pharmaceutical company. Teva Pharmaceuticals has demonstrated impressive progress in its transformation journey, underscored by resilience and strategic execution. With 2025 underway, Teva is well-positioned for continued growth, and its share price could approach $30 in the next 12–18 months, reflecting strong fundamentals and strategic advancements. Central to Teva's momentum is its leadership in the emerging anti-TL1A drug class, exemplified by the groundbreaking success of duvakitug. This experimental drug for ulcerative colitis (UC) and Crohn's disease (CD) achieved be
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025GlobeNewswire
- My Top 10 Portfolio Holdings for 2025 [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an "overweight" rating on the stock.MarketBeat
TEVA
Earnings
- 11/6/24 - Beat
TEVA
Sec Filings
- 12/26/24 - Form 4
- 12/20/24 - Form 144
- 12/4/24 - Form 4
- TEVA's page on the SEC website